Last reviewed · How we verify

NCT02760173

Verticality Perception - Effects of Prolonged Roll-tilt in Healthy Human Subjects

Withdrawn NA Last updated 2 July 2018
What this trial tests

NA trial testing perception of vertical after static roll-tilt over 5min in Vestibular. Withdrawn.

Timeline
1 June 2016
Primary endpoint
1 July 2016
28 June 2018

Quick facts

Lead sponsorUniversity of Zurich
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Start date1 June 2016
Primary completion1 July 2016
Estimated completion28 June 2018

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

Adults 18 to 65, any sex, with Vestibular or Perception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The long-term goal of this research is to advance our knowledge of how the brain combines the information of multiple sensory systems coding for spatial orientation and how adaptation to vestibular imbalance influences spatial orientation. In healthy human subjects verticality perception is accurate while upright. After prolonged roll-tilt, humans show a systematic bias in perceived direction towards the previous roll-tilted position (so-called "post-tilt bias"). Here we evaluate different potential explanations for this bias using both vision-dependent and vision-independent paradigms of verticality perception.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vestibular

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02760173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing